Rocket Pharmaceuticals, Inc. (RCKT) Social Stream
Rocket Pharmaceuticals Inc (RCKT) Price Targets From Analysts
Use the tables below to see what analysts covering Rocket Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 109 days, RCKT's average price target has gone down $3.75.
RCKT reports an average of 222.3% for its upside potential over the past 109 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RCKT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, RCKT's average broker recommendation rating improved by 0.67.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCKT as an investment opportunity.
- In terms of how Rocket Pharmaceuticals Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 647.58% of that group.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Rocket Pharmaceuticals Inc's variance in analysts' estimates is lower than -4.44% of them.
- RCKT has a greater average analyst price target than 539.6% of Pharmaceutical Products stocks.
- In the context of Pharmaceutical Products stocks, Rocket Pharmaceuticals Inc's number of analysts covering the stock is greater than 519.03% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Rocket Pharmaceuticals Inc are QURE, PTGX, and PTCT.
Is RCKT a Buy, Hold or Sell? See the POWR Ratings now!